<DOC>
	<DOCNO>NCT02673567</DOCNO>
	<brief_summary>This single center , randomize , double-blind , placebo-controlled study ass pharmacokinetics , safety , tolerability subcutaneous administration TEV-48125 ( single ascending dos single dos 900 mg ) Japanese Caucasian healthy subject .</brief_summary>
	<brief_title>To Assess Pharmacokinetics , Safety Tolerability TEV-48125 Japanese Caucasian Healthy Subjects After Single Subcutaneous ( SC ) Administration TEV-48125</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>The subject man woman , 18 55 year age , inclusive The subject body mass index ( BMI ) range 17.5 28.0 kg/m2 , inclusive The subject must good health screen checkin Additional inclusion criterion Japanese subject : Subject must nonnaturalized Japanese citizen hold Japanese passport Subject must have/had 2 Japanese parent 4 Japanese grandparent non naturalize Japanese citizen Subject living outside Japan 10 year Additional inclusion criterion Caucasian subject : The subject has/had 2 Caucasian parent 4 Caucasian grandparent . Caucasian include White Hispanic ethnicity . Additional criterion apply , please contact investigator information The subject woman pregnant lactate The subject suffering , clinically significant history , 1 following : cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , neurological , immunological , hematologic psychiatric disorder ( ) The subject know allergy sensitivity inject protein , include monoclonal antibody , component formulation . In addition , presence history allergy require acute chronic treatment Precipitation another clinical study new investigational drug within 30 day ( 90 day biologics ) dose Additional criterion apply , please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>